SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
122 hedge funds and large institutions have $34.5M invested in SANGAMO THERAPEUTICS INC in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 28 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 33
4% less call options, than puts
Call options by funds: $1.77M | Put options by funds: $1.84M
5% less funds holding
Funds holding: 128 → 122 (-6)
6.12% less ownership
Funds ownership: 29.51% → 23.39% (-6.1%)
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
45% less capital invested
Capital invested by funds: $62.9M → $34.5M (-$28.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.61M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.12M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$990K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$588K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$359K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$4.13M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.5M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.78M |
| 4 |
Millennium Management
New York
|
-$1.66M |
| 5 |
Morgan Stanley
New York
|
-$1.2M |
SGMO Hedge Fund Activity: Q1 2025 in Review
122 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2025, worth a combined $34.5M — down 45% from $62.9M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of SGMO and 23 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 33 added.
The largest buyer was Susquehanna International Group, adding an estimated $1.61M. The largest seller was State Street, cutting an estimated $4.13M.
- 122 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2025, down from 128 in Q4 2024.
- Funds reported $34.5M of SANGAMO THERAPEUTICS INC stock for Q1 2025, down 45% quarter-over-quarter.
- 23 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2025 and 28 closed out, a net change of -5 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q1 2025 was Susquehanna International Group, an estimated $1.61M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q1 2025 was State Street, an estimated $4.13M sold.
Based on aggregated 13F filings for Q1 2025.